FL-41 vs NeuroCalm FLX+: Single-Band vs Dual-Band Migraine Lenses
By Suraj Dubey — Senior Optometrist, Founder & Head of R&D, Sleepaxa Private Limited · Last updated: July 2026
Disclaimer: Educational content, not medical advice. FL-41 and NeuroCalm FLX+ lenses are designed for visual comfort and light-sensitivity management, not as a cure for migraine. Persistent migraine or photophobia should be evaluated by a clinician. Lab values are from independent ISO 12312-1 / ANSI Z80.3 reports.
Reviewed by: Dr. Monica Chaudhry — former AIIMS faculty (Clinical Advisor, Sleepaxa).
FL-41 is a proven, 30-year rose-tinted migraine lens — and Sleepaxa sells it in both Light and Dark. Its limitation is that it targets one of the two retinal pain pathways: the blue-cyan band (~480–520 nm). NeuroCalm FLX+ (Sleepaxa's patented lens, Patent No. 587746) is dual-band — it keeps the FL-41 blue-cyan attenuation and adds a second notch at the 585–600 nm amber band that Harvard research identified, while preserving the pain-reducing green. Choose FL-41 as the proven, accessible option; choose NeuroCalm FLX+ for the complete dual-pathway upgrade.
First — FL-41 Genuinely Works
FL-41 (a precise rose/mauve tint developed at the University of Utah in 1991) is one of the few lens tints with real clinical history for light sensitivity. Good et al. (1991) reported reduced migraine frequency in children, and Reyes et al. (2024) showed FL-41 reduces activation of the neural pathways involved in photophobia. This is why Sleepaxa offers a proper FL-41 line — we're not replacing it, we're building on it.
The Science: Migraine Light Sensitivity Has TWO Pathways
Harvard researcher Dr. Rodrigo Noseda mapped how light amplifies migraine pain — and found it travels through two separate retinal routes that converge on the same pain neurons:
FL-41's Honest Limitation: Single-Band
Classic FL-41 is a single-dye tint tuned to the blue-cyan band. Our own lab measurements confirm it: Sleepaxa FL-41 Dark attenuates roughly 87% of 480–520 nm light (transmission ~12–13% across that band) — excellent for Pathway 1. But at 580–590 nm it transmits ~64–75%, meaning the amber Pathway 2 largely passes through. That's not a flaw in FL-41; it's simply what a single-band tint does. For many people, addressing Pathway 1 is enough. For others — especially strong photophobia — the second pathway matters.
NeuroCalm FLX+: Dual-Band by Design
NeuroCalm FLX+ is Sleepaxa's patented lens (Patent No. 587746, application 202521094370, all 10 claims granted) engineered as a dual-band notch filter. Independent lab data shows it attenuates both pain bands while keeping the beneficial green relatively open:
- Blue-cyan (480–520 nm): transmission ~17–23% — attenuated, like FL-41.
- Amber (580–600 nm): transmission ~19–20% — notched down, unlike single-band FL-41.
- Green (~530 nm): relatively preserved (~24%) — the pain-reducing band stays comparatively open.
- Overall: VLT 21.72%, Category 2, so it's usable indoors and for daytime road use.
Sleepaxa Migraine Lens Line-Up (Lab-Verified)
| FL-41 Light | FL-41 Dark | NeuroCalm FLX+ | |
|---|---|---|---|
| VLT (brightness) | ~60% (lightest) | 41.10% | 21.72% |
| Pathway 1 · blue-cyan 480–520 nm | Attenuated (~82%) | Attenuated (~87%) | Attenuated |
| Pathway 2 · amber 585–600 nm | Mostly passes | Mostly passes | Notched (dual-band) |
| Green ~530 nm (preserve) | Preserved | Preserved | Preserved |
| Bands targeted | Single | Single | Dual |
| Patent | — | — | IN 587746 (granted) |
| Best for | Everyday indoor, mild sensitivity, subtle look | Stronger indoor/screen photophobia | Complete dual-pathway protection |
FL-41 Light — everyday indoor wear, milder light sensitivity, most natural appearance. FL-41 Dark — stronger indoor/screen photophobia where you want deeper blue-cyan attenuation. NeuroCalm FLX+ — the complete option when you want both pain pathways addressed, backed by a granted patent. All three preserve the pain-reducing green band and are available in zero power or full prescription.
Find Your Migraine Lens
FL-41 Light & Dark · patented NeuroCalm FLX+ · zero-power & full prescription (single-vision, progressive, bifocal, prism) · custom lens-fit for your own frame.
Shop Migraine Glasses Ask an Expert on WhatsAppFrequently Asked Questions
References
1. Good PA, et al. (1991) Tinted spectacles in childhood migraine. Cephalalgia.
2. Noseda R, et al. (2010) Neural mechanism for exacerbation of headache by light. Nat Neurosci. 13:239–245.
3. Noseda R, et al. (2016) Migraine photophobia from cone-driven retinal pathways. Brain. 139:1971–1986.
4. Reyes N, et al. (2024) FL-41 tint reduces activation of neural pathways of photophobia. Am J Ophthalmol. 259:172–184.
5. Sleepaxa / Acieon Labs lens test reports — ISO 12312-1, ANSI Z80.3 (2026); India Patent No. 587746.
Suraj Dubey is Founder & Head of R&D at Sleepaxa Private Limited. Inventor of NeuroCalm FLX+™ (Patent 587746). ORCID: 0009-0003-7510-9254.








